MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-56-0018401
Hatvet Pharma Private Limited - pharma in Meerut, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.73 Cr
▲ 24% YoY
Net profit · FY 2025
₹26.82 Lakh
Net margin 3.1%
EBITDA · FY 2025
₹92.73 Lakh
EBITDA margin 10.6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Satisfied charges
₹2.09 Cr
No open charges
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Hatvet Pharma Private Limited
Data last updated:
Hatvet Pharma Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 29 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51397UP2019PTC112978. Its GSTIN is 09AAECH7947J1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Rajnish Tyagi (Managing Director) and Rashmi Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 12 G Pocket Main Divider Road Ganga Nagar, Meerut, Uttar Pradesh, India – 250001.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.73 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹26.82 Lakh (net margin 3.1%) and EBITDA of ₹92.73 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 87% over five years.
The company is associated with 1 brand: Hatvet Pharma. As per MCA filings, the company has satisfied charges of ₹2.09 Cr on record.
Hatvet Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0018401). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hatvet.com.
Company details
CIN U51397UP2019PTC112978
Registration Number 112978
Incorporation Date 29 January 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-56-0018401
Recognitions & Rankings of Hatvet Pharma
Contact details
Hatvet Pharma Private Limited's registered office is in Meerut, Uttar Pradesh. Its website is hatvet.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC – 12 G Pocket Main Divider Road Ganga Nagar, Meerut, Uttar Pradesh, India – 250001
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Hatvet Pharma Private Limited, buy the company report.
Comprehensive company report
Hatvet Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hatvet Pharma operates one associated brand: HATVET PHARMA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Veterinary pharmaceutical products and grooming services in India. | hatvet.com |
Business activity
The main business activity of Hatvet Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hatvet Pharma Private Limited, buy the company report.
Financials of Hatvet Pharma Private Limited
FY 2025 filings availableHatvet Pharma Private Limited reported revenue of ₹8.73 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹8.73 Cr ▲ 24%
Net profit · FY 2025
₹26.82 Lakh margin 3.1%
EBITDA · FY 2025
₹92.73 Lakh margin 10.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 28%
5 years · compounded
▲ 87%
EBITDA CAGR growth
1 year
▲ 50%
3 years · compounded
▲ 83%
5 years · compounded
▲ 67%
Revenue has grown at a compounded annual rate (CAGR) of 87% over five years, including 24% growth in the latest year. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹92.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hatvet Pharma Private Limited, buy the company report.
Board of directors of Hatvet Pharma Private Limited
Hatvet Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmi Tyagi Also directs: Hatvet Pet Passion Private Limited, Hatvet Petzone Foundation | Director | 29 Jan 2019 | 7 Years 9 Months | Current |
| Rajnish Tyagi Also directs: Hatvet Pet Passion Private Limited, Hatvet Petzone Foundation | Managing Director | 29 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Hatvet Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Animal Pharma), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sylon Bio Pharma Private Limited | ₹9.22 Cr (FY 2025) | 49.0% | Hyderabad, Telangana, India | |||
| Irides Life Wellness Solutions Private Limited | ₹9.03 Cr (FY 2025) | -37.0% | Bangalore, Karnataka, India | |||
| Bionnar Health Care Private Limited | ₹8.97 Cr (FY 2024) | 7.0% | Mumbai, Maharashtra, India | |||
| Kepler Vet Mission Private Limited | ₹8.88 Cr (FY 2025) | -3.0% | Ahmedabad, Gujarat, India | |||
| Hatvet Pharma Private Limitedthis company | ₹8.73 Cr (FY 2025) | ₹26.82 Lakh | 3.1% | 24.0% | Meerut, Uttar Pradesh, India | |
| Pharmacon Vet Private Limited | ₹8.71 Cr (FY 2025) | -20.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Hatvet Pharma Private Limited, buy the company report.
Auditor
Hatvet Pharma Private Limited is audited by N K SALUJA & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N K SALUJA & Co. | FY 2023 | 002238C |
Shareholding
The shareholding of Hatvet Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hatvet Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹2.09 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Dec 2022 | 100663646 | State Bank of India | ₹1.2 Cr | Satisfied | |
| 13 Mar 2020 | 100331197 | State Bank of India | ₹89 Lakh | Satisfied |
To see the full charge records of Hatvet Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Hatvet Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Hatvet Pharma Private Limited has 4 MSME Form 1 returns on record between 2020 and 2023, listing 6 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hatvet Pet Passion Private Limited | |||
| an individual supplier | |||
| Zaneka Healthcare Limited | |||
| Zaneka Drugs | |||
| an individual supplier |
To see the full MSME payment records of Hatvet Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Hatvet Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECH7947J1Z0 | Uttar Pradesh | Active | 14 Feb 2019 |
To see the full GST registrations and return filing status of Hatvet Pharma Private Limited, buy the company report.
Recent activity
Hatvet Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Rajnish Tyagi was appointed as Managing Director on 29 Jan 2019.
AGM
Hatvet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hatvet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Charges
A charge registered on 13 Dec 2022 via Charge ID 100663646 with State Bank Of India was fully satisfied on 05 Jun 2024.
Charges
A charge with State Bank Of India of Rs. 120.00 Lakh registered on 13 Dec 2022 with Charge ID 100663646 was modified on 17 Jan 2024.
Charges
A charge with State Bank Of India amounted to Rs. 120.00 Lakh with Charge ID 100663646 was registered on 13 Dec 2022.
Charges
A charge registered on 13 Mar 2020 via Charge ID 100331197 with State Bank Of India was fully satisfied on 17 May 2022.
Charges
A charge with State Bank Of India of Rs. 89.00 Lakh registered on 13 Mar 2020 with Charge ID 100331197 was modified on 23 Dec 2021.
Charges
A charge with State Bank Of India amounted to Rs. 89.00 Lakh with Charge ID 100331197 was registered on 13 Mar 2020.
Appointed
Rajnish Tyagi was appointed as Managing Director.
Appointed
Rashmi Tyagi was appointed as Director.
Incorporation
29 Jan 2019
Hatvet Pharma Private Limited was registered on 29 Jan 2019 with Roc Uttar Pradesh Ii & aged 7 years 9 months as per MCA records.
Frequently asked questions
Hatvet Pharma is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 29 January 2019 (7+ years old) and is registered under CIN U51397UP2019PTC112978.
Hatvet Pharma has 2 current directors:
- Rajnish Tyagi - Managing Director
- Rashmi Tyagi - Director
The latest financial statements of Hatvet Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Hatvet Pharma is 09AAECH7947J1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Hatvet Pharma is U51397UP2019PTC112978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hatvet Pharma was incorporated on 29 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Hatvet Pharma by revenue are Sylon Bio Pharma Private Limited, Irides Life Wellness Solutions Private Limited, Bionnar Health Care Private Limited, Kepler Vet Mission Private Limited, Pharmacon Vet Private Limited, all in the Pharma industry (Animal Pharma), with the same principal business activity (wholesale trading).
Rajnish Tyagi was appointed as Managing Director on 29 Jan 2019. Rashmi Tyagi was appointed as Director on 29 Jan 2019.
Yes, Hatvet Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-56-0018401).
Hatvet Pharma has 4 MSME Form 1 returns on record between 2020 and 2023, listing 6 overdue payments to 5 micro and small suppliers. The latest return was filed on 16 Dec 2023.
Hatvet Pharma can be reached through the website hatvet.com. Its registered office is in Meerut, Uttar Pradesh, India.
The registered office of Hatvet Pharma is at C – 12 G Pocket Main Divider Road Ganga Nagar, Meerut, Uttar Pradesh, India – 250001.